CLINICAL_TRIALS
trial_result
· 2025-05-04
Clinical Trial Update: Alternate Day Prednisone or Daily Fish Oil Supplements in Patients With Immunoglobulin A Nephropathy [Phase 2]
Summary
A Phase 2 clinical trial evaluating alternate-day prednisone versus daily fish oil supplements for IgA nephropathy has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: IgA Glomerulonephritis | Phase 2 | Status: COMPLETED